The fact that Morgans cited this in their research report as justification to re-evaluate their price target for PAR just goes to show what they truly know and the level of expertise of the staff they have working on the PAR question. I've seen some quality reports come out from Morgans for other companies, but their coverage of PAR seems to be consistent with the low-level arguments from some HC posters who continually attempt to misinform other posters.
A very wise CEO once told me obtaining patent protection from USPTO is like horse trading: you want to find out the stance of the USPTO before playing your own hand. The more recent update shows PAR exactly where the USPTO stands and exactly what PAR needs to do to overcome their objections. As I mentioned yesterday, PAR can overcome these objections by highlighting the durability associated with iPPS which can be used to overcome the "obviousness" argument. Expect PAR to arrange a phone call in the next month or two with the patent examiner and expect them to replace the final rejection with a non-final rejection.
All in my opinion of course.
- Forums
- ASX - By Stock
- PAR
- Ann: Clarification of recent analyst report on Patent Protection
Ann: Clarification of recent analyst report on Patent Protection, page-9
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
0.015(6.67%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $173.6K | 743.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 131244 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 99346 | 0.225 |
5 | 44676 | 0.220 |
7 | 82313 | 0.215 |
13 | 181424 | 0.210 |
8 | 128042 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 131244 | 5 |
0.245 | 56918 | 2 |
0.250 | 89857 | 4 |
0.255 | 100000 | 1 |
0.260 | 1333 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online